Clostridium difficile is posing urgent health threats. Older studies have shown that metronidazole and vancomycin are equally effective in the treatment of Clostridium difficile infection (CDI). Given its inexpensive cost and low propensity to select antimicrobial resistant organisms, metronidazole became rapidly the drug of choice despite its pharmacokinetic limitations in the treatment of CDI. However, newer studies demonstrated that metronidazole is inferior to vancomycin, prompting clinicians to change their long-standing position on using metronidazole for mild to moderate infections and on reserving vancomycin for severe infections. Moving forward, metronidazole will fall out of favor in the treatment of CDI.
LessaFCMuYBambergWMet al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372:825-834.
3.
LefflerDALamontJT.Clostridium difficile infection. N Engl J Med. 2015;372:1539-1548.
4.
SilvaJJrBattsDHFeketyRPlouffeJFRifkinGDBairdI.Treatment of Clostridium difficile colitis and diarrhea with vancomycin. Am J Med. 1981;71:815-822.
5.
TeasleyDGGerdingDNOlsonMMet al. Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis. Lancet. 1983;2:1043-1046.
6.
WenischCParschalkBHasenhündlMHirschlAMGraningerW.Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. Clin Infect Dis. 1996;22:813-818. (Erratum in: Clin Infect Dis. 1996;23:423)
7.
Hospital Infection Control Practices Advisory Committee (HICPAC). Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol. 1995;16:105-113.
8.
GerdingDNJohnsonSPetersonLRMulliganMESilvaJJr.Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol. 1995;16:459-477.
9.
FeketyR.Guidelines for the diagnosis and management of Clostridium difficile–associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 1997;92:739-750.
10.
ASHP therapeutic position statement on the preferential use of metronidazole for the treatment of Clostridium difficile-associated disease. Am J Health Syst Pharm. 1998;55:1407-1411.
11.
ZarFABakkanagariSRMoorthiKMDavisMB.A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis. 2007;45:302-307.
12.
SethiAKAl-NassirWNNerandzicMMDonskeyCJ.Skin and environmental contamination with vancomycin-resistant Enterococci in patients receiving oral metronidazole or oral vancomycin treatment for Clostridium difficile-associated disease. Infect Control Hosp Epidemiol. 2009;30:13-17.
13.
CohenSHGerdingDNJohnsonSet al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31:431-455.
14.
SurawiczCMBrandtLJBinionDGet al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013;108:478-498.
15.
DebastSBBauerMPKuijperEJ; European Society of Clinical Microbiology and Infectious Diseases. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2014;20(suppl 2):1-26.
16.
JohnsonSLouieTJGerdingDNet al; Polymer Alternative for CDI Treatment (PACT) Investigators. Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials. Clin Infect Dis. 2014;59:345-354.
17.
DiXBaiNZhangXet al. A meta-analysis of metronidazole and vancomycin for the treatment of Clostridium difficile infection, stratified by disease severity. Braz J Infect Dis. 2015;19:339-349.
18.
SiegfriedJDubrovskayaYFlagielloTet al. Initial therapy for mild to moderate Clostridium difficile infection: exploring the role of oral metronidazole versus vancomycin in 168 hospitalized patients. IDCP. 2016;24:210-216.
19.
BarkinJASussmanDAFifadaraNBarkinJS.Clostridium difficile infection and patient-specific antimicrobial resistance testing reveals a high metronidazole resistance rate. Dig Dis Sci. 2017;62:1035-1042.
20.
StevensVWNelsonRESchwab-DaughertyEMet al. Comparative effectiveness of vancomycin and metronidazole for the prevention of recurrence and death in patients with Clostridium difficile infection. JAMA Intern Med. 2017;177:546-553.
21.
ShaneALModyRKCrumpJAet al. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. 2017;65:e45-e80.
